These findings were in agreement with those which showed that AMPK activation by pharmaceutical drugs suppressed the TGF-β1-induced collagen production in lung fibroblasts and protected against bleomycin-induced mouse lung fibrosis [30,35,36]. Here, PRKAA1 is linked to pulmonary fibrosis.